Edward D. Hamilton serves as Executive at SAB Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Edward D. Hamilton has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 22, 2021 involved receiving (via award) 4,974,497 shares valued at $0.
Edward D. Hamilton currently holds 4,974,497 shares of SAB Biotherapeutics, Inc. (SABS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward D. Hamilton has been a net neutral trader of SABS stock. They have purchased $0 and sold $0 worth of shares.
Edward D. Hamilton's most recent insider trade was on Oct 22, 2021, when they sold 4,974,497 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 14, 2021 | SABS | $51.4K | Award | 5,092 | $10.10 | Discretionary |
| Oct 13, 2021 | SABS | $210.1K | Award | 20,800 | $10.10 | Discretionary |
| Oct 12, 2021 | SABS | $252.0K | Award | 25,000 | $10.08 | Discretionary |
| Oct 12, 2021 | SABS | $252.3K | Award | 25,000 | $10.09 | Discretionary |
| Oct 1, 2021 | SABS | $27.2K | Award | 2,695 | $10.10 | Discretionary |